A family of five neutral cyclometalated iridium(III) tetrazolato complexes and their methylated cationic analogues have been synthesised and characterised. The complexes are distinguished by variations of the substituents or degree of π conjugation on either the phenylpyridine or tetrazolato ligands. The photophysical properties of these species have been evaluated in organic and aqueous media, revealing predominantly a solvatochromic emission originating from mixed metal-to-ligand and ligand-to-ligand charge transfer excited states of triplet multiplicity. These emissions are characterised by typically long excited state lifetimes, with values around hundreds of nanoseconds, and quantum yields around 5-10% in aqueous media. Methylation of the complexes caused a systematic red-shift of the emission profiles. Changes in the chemical structure of the neutral cyclometalated iridium(III) tetrazolato species resulted in complexes that imaged the endoplasmic reticulum and lipid droplets. On the other hand, the majority of the cationic complexes interacted with mitochondria. The amount of complexes found within cells varied considerably, even between complexes showing similar values of lipophilicity, which potentially suggests diverse mechanisms of entrance. Methylation of the complexes evidenced more pronounced cytotoxicity with respect to the neutral species, a behavior that might to be linked to a combination of uptake and intracellular localisation.
Introduction
Luminescent metal complexes of transition [e.g. Ru(II), Re(I), Ir(III), Au(I), and Pt(II)] [1] [2] [3] [4] and lanthanoid elements [e.g. Eu(III) and Tb(III) for visible emission; Yb(III) for near-infrared emission] [5, 6] have specific photophysical properties that are ideal for cellular imaging. These properties have the potential to solve some of the critical drawbacks associated with more traditionally investigated organic fluorophores. [7] Appropriately designed metal complexes exhibit enhanced photostability, and therefore do not suffer from rapid photobleaching, thus allowing imaging on longer time scales. [1] Luminescent heavy metal complexes are also typically characterised by large Stokes shifts, which prevents concentration quenching phenomena. [1] Furthermore, their relatively longer excited state lifetimes make this class of luminophores amenable to time-gated imaging to improve signal-to-noise ratio by minimising interference from fast decaying autofluorescence. [8] Luminescent cyclometalated iridium(III) complexes are proving to be exceptional systems for the development of markers for live cell imaging. [9, 10] The chemical, photophysical, and biological targeting properties of these complexes can be readily varied by altering the coordinating ligands or by chemical coupling. [11, 12] In addition, their absorption and emission profiles can be modulated along the spectral range of visible light from blue to red, and further into the near-infrared region, by introducing appropriate functional groups or by the variation of the π conjugation on the aromatic ligands. [13, 14] Following similar principles, the lipophilicity of these complexes can be adjusted to favour transport across the cellular membrane, while maintaining adequate solubility in aqueous media. [1, 15] A large number of luminescent iridium complexes have been reported to possess not only the capacity to internalise into cells, [13, 16] but also the ability to accumulate within specific organelles such as mitochondria, [17] [18] [19] [20] [21] [22] lysosomes, [15, [23] [24] [25] nuclei, [26] [27] [28] [29] [30] and endoplasmic reticulum. [31] [32] [33] [34] Some iridium complexes have been conjugated with biologically relevant moieties such as carbohydrates, [18, 35] biotin/avidin, [36] [37] [38] [39] amino acids, [23] and proteins [40] , in an attempt to impart and control their biospecificity. Furthermore, examples of complexes with the ability to sense targeted biological species via reversible or irreversible modulation of their photophysical properties have also been reported. [21, 27, 34, [41] [42] [43] [44] [45] [46] [47] A rationalisation of the structure-activity relationship (SAR) of luminescent iridium complexes is still difficult to achieve from the current knowledge base. This is partly due to the fact that labelling experiments are often carried out with a diverse range of complexes using different cell lines or model systems. Moreover, the staining protocols used are often variable when comparing data from different research groups. [48] In addition, a priority has been given to producing cationic iridium complexes, seemingly arising from the fact that they might possess increased solubility in aqueous media and exhibit more favourable membrane transport by exploiting membrane potential gradients. However, many of these molecular complexes have exhibited moderate to acute cytotoxicity, a property that can be regarded favourably for the joint development of therapeutics, [22, 24, [49] [50] [51] but which is not ideal for visualising cellular functions in live cell systems.
Notably, only a handful of neutral iridium complexes have been investigated as cellular imaging agents. [15, 23, 25, 47, 52, 53] We previously showed that neutral luminescent rhenium(I) complexes can be used for live cell imaging, offering different biospecificity to the more popularly investigated cationic rhenium complexes. [54] For example, we demonstrated unprecedented staining of polar lipids in live cells using the complex fac-[Re(CO) 3 (phen)L] (L = 5-(4-cyanophenyl)tetrazolate; phen = 1,10phenanthroline). [55, 56] Furthermore, simple chemical modulation of the tetrazolato ancillary ligand has been a viable strategy to impart alternative biological behaviour, with successful staining of the endoplasmic reticulum and the visualisation of membrane events in live cells. [57] We have now focused our attention on the investigation of cyclometalated iridium complexes bound to tetrazolato ligands, which is a family of neutral and analogous cationic iridium species that have not been previously used as molecular probes for live cell imaging. For this scope, we prepared an initial library of complexes by modifying the functional groups on the ligands and by the extension of the π conjugation ( Figure 1 ). Due to the intrinsic reactivity of the coordinated tetrazolato ligand towards electrophiles, [11, 58, 59] these neutral complexes could also be easily methylated, allowing the preparation of the analogous cationic species. This approach allowed the preparation of a family of complexes for a more systematic SAR investigation that can relate how variations in the chemical structure and charge might influence the biological behaviour of the iridium markers in relation to cellular incubation, localisation, and cytotoxicity. 
Results and Discussion

Synthesis of the tetrazolato ligands and corresponding iridium complexes
The adopted synthetic procedures are shown in Figure 2 . The ligand precursor 2,5-dicyanopyridine was obtained in three steps starting from commercially available 2,5-pyridinedicarboxylic acid.
Following a Fisher esterification to form the corresponding methyl ester groups, aminolysis with aqueous ammonia gave the corresponding primary amides. Lastly, dehydration of the amide groups yielded the desired nitrile moieties. [60] Following a methodology developed by Sharpless, [61] 2,5- , the corresponding chloro-bridged iridium dimers (bearing either ppy or F 2 ppy as cyclometalating ligands) were reacted with a slight excess of the corresponding pyridyl or (iso)quinolyl tetrazolato species. [11] The complex [Ir(ppy) 2 (TzPyPhCN)] was prepared via a different route, involving a Suzuki coupling of the previously reported [Ir(ppy) 2 (TzPyBr)] [11] with 4-cyanophenylboronic acid. Previous attempts to react the iridium chloro-bridged dimer with the pre-formed corresponding tetrazolato ligand were unsuccessful, as an inseparable mixture of products was obtained. Methylation of all the neutral complexes was performed by treatment with methyl trifluoromethanesulphonate, followed by metathesis with ammonium hexafluorophosphate. [11] All the synthesised complexes were characterised by means of NMR (see SI for all the 1 H and 13 C spectra) and IR spectroscopy as well as elemental analysis.
X-ray Structural Determination
Single crystals suitable for X-ray diffraction were obtained for the neutral [Ir(F 2 ppy) 2 
Photophysical Properties
A summary of the photophysical properties for the synthesised iridium complexes, measured from dichloromethane and aqueous (ca 10 -5 M) solutions are listed in Table 1 (see SI for and lipid-rich compartments like membranes, endoplasmic reticulum, and lipid droplets. The photophysical properties were measured in air-equilibrated solutions to account for the presence of oxygen in live cells. However, to confirm triplet multiplicity of the excited states, the measurements were also performed in degassed dichloromethane solutions. [62] The absorption spectra from air-equilibrated dichloromethane solutions are presented in Figure 4 (for the spectral profiles in other solvents see SI). All the iridium complexes show intense absorption bands in the UV region (250-300 nm), which are associated with ligand-centred (LC) ππ* transitions, followed by bands of lower intensity tailing off into the visible region of the spectra.
These lower energy bands are ascribed to spin allowed (singlet to singlet) and spin forbidden (singlet to triplet) ligand-to-ligand (LLCT) and metal-to-ligand charge transfer (MLCT)
transitions. [11] Excitation of the iridium complexes at 375 nm results in long-lived orange to red emission in airequilibrated dichloromethane solutions, and the emission spectra measured at 298 K are shown in Figure 5 (for the emission spectra in other solvents see SI). The neutral complexes [Ir(ppy) 2 (TzPyCN)], [Ir(F 2 ppy) 2 (TzPyCN)], and [Ir(ppy) 2 (TzPyPhCN)] are characterised by broad and featureless emission bands, that are typical for radiative decays from excited states of charge transfer character. [12] The [Ir(ppy) 2 (TzPyCN)] complex presents a red-shifted maximum at 618 nm, which is ascribed to a stabilisation of the unoccupied π* orbitals localised on the TzPyCNligand caused by the electron-withdrawing nature of the nitrile functional group. [11] As expected, the addition of electron-withdrawing fluoride substituents on the ppy ligands causes a blue-shift of the emission maximum for [Ir(F 2 ppy) 2 (TzPyCN)] (λ em = 542 nm), as a consequence of the stabilisation of the occupied π orbitals of the ligands and iridium 5d orbitals composing the mixed LLCT(F 2 ppy→TzPyCN) and MLCT(Ir→TzPyCN) transition. [11] The emission maximum of complexes. Once more, this red-shift demonstrates that the π* system of the pyridyl tetrazole ligand acts as an electron acceptor in the charge transfer transitions. [11, 63] When comparing the emission maxima of these three methylated iridium complexes, the trend for the emission properties is analogous to that observed for their neutral counterparts, with the most red-shifted emission originating from [Ir(ppy) 2 
The iridium complexes containing quinoline and isoquinoline-functionalised tetrazolato ligands, [Ir(ppy) 2 (TzQn)] and [Ir(ppy) 2 (TziQn)], reveal emission bands that are similarly ranging between 500 and 750 nm ( Figure 5 ). Compared to the previously published complex [Ir(ppy) 2 (TzPy)], [11] where TzPyis 5-(2'-pyridyl)tetrazolate, displaying a structured emission band with peaks at 481 and 510 nm, the complexes [Ir(ppy) 2 (TzQn)] and [Ir(ppy) 2 (TziQn)] present a red-shifted emission that is rationalised by the increased π conjugation on passing from a phenyl to a quinolyl or isoquinolyl substituent. The structures of these two bands appear to be quite different. The emission profile of [Ir(ppy) 2 (TzQn)] is broad and structureless, whereas that of [Ir(ppy) 2 (TziQn)] appears to be structured with a vibronic progression spaced around 1,300 cm -1 . Furthermore, the excited state lifetime of [Ir(ppy) 2 (TziQn)] is significantly longer than that of [Ir(ppy) 2 (TzQn)] ( Table 1) . These results suggest the presence of a more dominating charge transfer character for the emission of [Ir(ppy) 2 (TzQn)]. [64] On the other hand, the excited state of [Ir(ppy) 2 (TziQn)] seems to be strongly influenced by LC character. [64] To confirm this assumption, we performed time dependent density functional theory (TD-DFT) analysis on [Ir(ppy) 2 (TzQn)] and [Ir(ppy) 2 (TziQn)] (see SI). The results show that the lower energy bands are mainly composed of MLCT and LLCT transitions.
However, in the case of [Ir(ppy) 2 (TziQn)], there is also a contribution from the HOMO-4→LUMO transition corresponding to a LC transition localised on the TziQnligand. A further indication of the LC character of the excited state of [Ir(ppy) 2 (TziQn)] comes from the significantly elongated excited state decay lifetime in degassed dichloromethane, reaching a value of 6.713 µs. [65] As expected, the emission profiles of the methylated [Ir(ppy) 2 (MeTzQn)] + and [Ir(ppy) 2 (MeTziQn)] + complexes appear red-shifted, broad, and structureless ( Figure 5 ).
For all the complexes, an elongation of the excited state lifetime decay (τ) and increase of photoluminescence quantum yield (Φ) values is observed upon degassing. This behaviour is indicative of the triplet spin multiplicity of the excited state. [12, 62] The analysis of the emission bands in various solvents reveals solvatochromic behaviour, with a appreciable emission only in dichloromethane solution, as the complex is virtually non-emissive in aqueous solvents. In general, the methylated complexes highlight a greater degree of quenching in aqueous solvents with respect to their neutral analogues. While conclusive explanations cannot be drawn from these data, potential causes could be ascribed to increased non-radiative decays due to energy gap law and the higher solubility of the cationic complexes in aqueous solvents. In fact, we previously observed a similar behavior for neutral rhenium complexes, where a decrease of solubility in aqueous media showed an enhanced quantum yield and elongated excited state lifetime. [54] 
Lipophilicity and cellular incubation
The lipophilicity of the iridium complexes was measured by the shake-flask method using a pH = 7.4 buffered PBS solution and n-octanol. [66] The calculated logD 7.4 values are listed in Table 2 . The values obtained are within a range that is similar to those reported previously for cyclometalated iridium complexes, [18, 24, 26, 53] and, in the case of the neutral complexes, fluorophores for the lipid droplets of the BODIPY family (functionalised 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene cores). [67] The values for the five neutral complexes are comprised between 2.01 and 2.68.
Methylation of the iridium complexes lowers the lipophilicity, which is ascribed to the introduction of the cationic charge, and results in logD 7.4 
Cellular uptake and localisation
The cellular uptake for the synthesised iridium complexes was studied by means of ICP-MS measurements, and the results are reported in Table 2 . The H9c2 cells were incubated with complexes at 20 µM in cell culture medium (0.2% DMSO) for 30 minutes at 37 °C. The calculated cellular concentration values were obtained assuming an average volume of a single H9c2 cell equal to 2 pL. [72] An analysis of the data reveals that the association between internalisation and lipophilicity does not follow a simple trend. For example, three of the neutral complexes, ligands exhibit efficient cellular internalisation. The lack of straightforward trends suggests that the mechanism of internalisation might be different for the various complexes.
The cellular localisation of the iridium complexes was investigated via confocal microscopy.
Following the same incubation protocol described for the ICP-MS measurements, complexes could be detected in cells by single photon excitation at 403 nm and were also shown to be compatible with two-photon imaging modalities, with optimal excitation in the range of 810-830 nm (see SI).
All the complexes could be readily detected within cells in an emission interval of 525-644 nm, (consistent with emissions recorded in the cuvette), allow for co-staining with commercially available organelle markers. The [Ir(ppy) 2 (MeTzPyCN)] + complexes was the only exception which had low detectability within the instrument range (420-740 nm) constant with measures taken in aqueous media, thus was omitted from co-localisation studies.
All the neutral complexes had similar staining patterns and evidenced a diffuse network emanating from the nucleus and extending into the cytoplasm (Figure 6 ), consistent with the endoplasmic reticulum (ER). In addition, the methylated cationic complex [Ir(ppy) 2 (MeTzQn)] + also detected this reticular network in the perinuclear region ( Figure 6 ). Co-staining with ER-Tracker™ revealed relatively high Pearson's correlation coefficients, [73] with values above 0.7, confirming these complexes localise within the ER (see SI). While the neutral complexes and the methylated cationic complex [Ir(ppy) 2 (MeTzQn)] + were predominately localised within the ER, their emission was also detected within compartments in the cytoplasm that were not labelled with ER-Tracker™. The morphology and localisation of these compartments resembled lipid droplets. BODIPY ® 500/510 C 1 ,C 12 , a fatty acid analogue that localises with lipid droplets and partially with the endoplasmic reticulum, produced strong co-localisation with these complexes (Figure 7) . A high Pearson's correlation coefficients was obtained for these complexes and BODIPY ® 500/510 C 1 ,C 12 (ranging between 0.63 and 0.92; see SI), [73] confirming that these compartments were lipid droplets.
Figure 7. Iridium complexes localise with lipid droplets in live H9c2 cells. Micrographs of H9c2
cells stained with the iridium complexes (green) and counter-stained with BODIPY ® 500/510 C 1 ,C 12 fatty acid analogue (red). Yellow/orange colour in the merge indicates marker colocalisation.
The iridium complexes were excited at 403 nm and the emission was collected in the region 525-644 nm; BODIPY500/510 was excited at 488 nm and the emission was collected in the region 500-550 nm. Scale bars: 10 µm.
The methylated complexes [Ir(F 2 ppy) 2 (MeTzPyCN)] + and [Ir(ppy) 2 (MeTzPyPhCN)] + localised to elongated structures throughout the cytoplasm, a staining pattern that is characteristics of mitochondrial association (Figure 8 ). Co-staining with MitoTracker ® Red CMXRos confirmed this interaction, with Pearson's correlation coefficient between 0.65 and 0.71 (see SI). [73] It is possible that the positive charge favours the transport of these complexes across the mitochondrial membrane as a consequence of the intermembrane electrical potential gradient. This explanation is consistent with the typical mitochondrial affinity of delocalised lipophilic cations such as phosphonium salts, or previously reported cationic metal complexes. [74] It is interesting to note that the complex [Ir(F 2 ppy) 2 (MeTzPyCN)] + also stained what appears to be the ER along with the mitochondria, although co-staining between the complex and ER-Tracker could not be performed (see SI). While [Ir(ppy) 2 (MeTziQn)] + also co-located with MitoTracker ® Red CMXRos, this charged complex appeared to induce apoptosis, characterised by the formation of cellular vacuoles and rounding of the mitochondria (Figure 8 ). In this case, ER-Tracker™ was also observed to colocalise with these unusual cellular structures. An increase of caspase activity in H9c2 cells after incubation with [Ir(ppy) 2 (MeTziQn)] + confirmed the induction of apoptosis (see SI). [75] Confocal microscopy was also employed to assess the mechanism of cellular internalisation. The intensity of the emission from the iridium complexes was compared between cells incubated at 37 and 4 °C (Figure 9 ), the latter to suppress energy-mediated mechanisms of entrance. The emission detected from each complex shows a good correlation with the average amount of iridium found in cells measured by ICP-MS ( the cellular uptake of these complexes, a result that is consistent with previously studied cyclometalated iridium complexes incubated in various cell lines. [17, 26, 42, 46, 76] Again, the lack of clear trends in Figure 9 suggests variable mechanism of entrance even for subtle chemical changes.
For example, [Ir(ppy) 2 (TzQn)] is detected well upon incubation at 4 °C, but [Ir(ppy) 2 (TziQn)] is barely visible, even though the two complexes differ only by the orientation of the quinolyl substituents and have very similar lipophilicity values. Our results reinforce previously reported views [48, 77] that conclusions based exclusively on lipophilicity measurements might not be adequate, even for families of complexes with very similar chemical structures.
Cytotoxicity
The cell viability was assessed via MTS assay to highlight cytotoxic effects after internalisation of the iridium complexes (without photoexcitation). The H9c2 cells were incubated for either 2 hours The only exception to the cytotoxic effect of the cationic complexes seems to be related to [Ir(ppy) 2 (MeTzPyCN)] + , which from the ICP-MS results showed minimal accumulation within the cells. Unfortunately however, the localisation of this compound could not be assessed due to its non-emissive nature in aqueous medium. It is well known that phosphorescent metal complexes act as sensitisers for singlet oxygen. [78] Therefore, during imaging with confocal microscopy a resting time of at least 30 seconds is always provided to the cells to recover from a potential increase in reactive oxygen species. This is a protocol we optimised during our previous studies using rhenium complexes as cellular labels. [79] Using this protocol, and imaging cells incubated for 30 minutes with a 20 µM solution of iridium complex, blebbing of the cell membrane was never observed. On the other hand, cells incubated under the same conditions and continuously illuminated showed signs of blebbing within a 30 minute timeframe (see SI). These results demonstrate that the neutral series of iridium tetrazolato complexes possess very promising properties for the development of iridium-based markers for imaging of the ER in live cells. This is in contrast to other cationic iridium complexes that were previously shown to accumulate in the endoplasmic reticulum, but which were cytotoxic due to the triggering of Ca 2+ release into the cytoplasm. [80] 
Photostability
Photobleaching experiments were carried out on H9c2 cells incubated with the iridium complexes at 20 µM for 30 minutes (see SI). The cells were illuminated continuously at 403 nm for 900 s, and the decrease in emission intensity was compared with that from cells incubated with ER-Tracker.
All the complexes evaluated in cells showed better photostability than ER-Tracker, with the cationic complexes exhibiting emission intensity above 85% of the initial values after 900 s irradiation. The neutral iridium complexes proved to be slightly more prone to photobleaching, but still displayed emission above 70% of the initial emission intensity after 900 s irradiation. The only exception was the fluorinated [Ir(F 2 ppy)(TzPyCN)], which showed a photobleaching profile just slightly slower that ER-Tracker. The data clearly highlight how the cationic complexes exhibit better photostability than their neutral analogues. The same general trend was also observed from photobleaching experiments in cuvettes using 10 -5 M aqueous solutions (0.2% DMSO), excited using a Pen-Ray Mercury Lamp source at 365 nm (see SI for experimental details).
Conclusions
This work reports the synthesis of iridium tetrazolato complexes and their potential use as imaging agents in live cells. A library of neutral complexes displaying chemical variations at the cyclometalating phenylpyridine and tetrazolato ligands was synthesised. Furthermore, methylation of these species allowed facile access to the corresponding cationic complexes, so that a SAR for cellular internalisation, localisation, and cytotoxicity could be more systematically investigated. The photophysical properties of these species revealed typical phosphorescent emission from excited states of charge transfer nature, as a mixture of 3 MLCT and 3 LLCT. The emission of the complexes was found to be in general solvatochromic, with a red-shift occurring upon increase of medium polarity. Quantification of cellular incubation via ICP-MS revealed great variability, with trends that cannot be simply correlated to the degree of lipophilicity and charge of the complexes. These results suggest potentially different mechanisms of uptake, and a comparison of the emission intensity from cells incubated at 37 and 4 °C reveals these are predominantly energy mediated. The majority of the complexes were internalised into cells and detection was possible via either onephoton or two-photon imaging modalities. The neutral species were predominantly localised within the endoplasmic reticulum and to various extents within lipid droplets. On the other hand, the cationic species exhibited more specificity for mitochondria. A marked difference between the neutral and cationic probes was found in terms of cytotoxicity, which was restricted mainly to the charged complexes during long term experiments. The higher cytotoxicity of the cationic complexes does not seem to be exclusively linked to the amount of complex internalised within the cells, and it is potentially highly dependent also on the localisation. This study has therefore highlighted that neutral iridium tetrazolato complexes are suitable building blocks for the design of markers for cellular imaging on long timescales, and more specifically for the imaging of ER and lipid droplets. However, specific protocols for imaging modalities (e.g. resting time between consecutive excitation regimes) are essential to avoid photocytotoxicity. On the other hand, cationic iridium tetrazolato complexes are good candidates for the design of mitochondrial markers.
However, careful considerations must be taken for longer time experiments, as these cationic complexes have demonstrated higher cytotoxicity with the respect to their neutral analogues.
Experimental Section
General Considerations
Unless otherwise stated, all reagents and solvents were purchased from Sigma Aldrich or Alfa
Aesar and used as received without further purification. The species HTzQn, [81] HTziQn, [81] [Ir(ppy) 2 (µ-Cl)] 2 , [82] [Ir(F 2 ppy) 2 (µ-Cl)] 2 [82] and [Ir(ppy) 2 (TzPyBr)] [11] were prepared according to previously published procedures. Detailed synthetic procedures for the iridium complexes and corresponding ligands described in this work are reported in the SI.
Nuclear magnetic resonance spectra were recorded using a Bruker Avance 400 spectrometer (400 MHz for 1 H NMR; 100 MHz for 13 C NMR) at 300 K. All NMR spectra were calibrated to residual solvent signals. Infrared spectra were recorded using an attenuated total reflectance Perkin Elmer Spectrum 100 FT-IR with a diamond stage. IR spectra were recorded from 4000-650 cm -1 . The intensity of the band is reported as strong (s), medium (m), or weak (w), with broad (br) bands also specified. Melting points were determined using a BI Barnsted Electrotermal 9100 apparatus.
Elemental analyses were carried out on bulk samples using a Thermo Finning EA 1112 Series Flash; the presence of solvents in the bulk samples was further confirmed by 1 H NMR.
X-ray crystallography
Crystallographic data for the structure were collected at 100(2) K on an Oxford Diffraction Gemini diffractometer with Mo Kα or Cu Kα radiation. Following absorption corrections and solution by direct methods, the structures were refined against F 2 with full-matrix least-squares using the program SHELXL-2014. [83] All hydrogen atoms were added at calculated positions and refined by use of riding models with isotropic displacement parameters based on those of the parent atoms.
Anisotropic displacement parameters were employed throughout for the non-hydrogen atoms.
Structure refinement data are reported in the SI.
Photophysical measurements
Absorption spectra were recorded at room temperature using a Cary 4000 UV/Vis spectrometer.
Uncorrected steady state emission and excitation spectra were recorded on an Edinburgh FLSP980-S2S2-stm spectrometer equipped with: i) a temperature-monitored cuvette holder; ii) 450 W Xenon arc lamp; iii) double excitation and emission monochromators; iv) a Peltier cooled Hamamatsu R928P photomultiplier tube (spectral range 200-870 nm). Emission and excitation spectra were corrected for source intensity (lamp and grating) and emission spectral response (detector and grating) by a calibration curve supplied with the instrument. According to the approach described by Demas and Crosby, [84] uncertainties are estimated to be ±8% for lifetime determinations, ±20% for quantum yields, ±2 nm and ±5 nm for absorption and emission peaks, respectively.
TD-DFT
Time-dependent density functional theory calculations were performed with GAUSSIAN 09. [86] €
Prior to these calculations, the structures were relaxed at the B3LYP level of theory. [87, 88] The Ir atoms were treated with the Stuttgart-Dresden effective core potential, [89] the Pople 6-311G** basis set was used for all the other atoms, and the effect of the solvent was mimicked with the PCM solvation model, [90] with parameters adequate for dichloromethane. The low-lying singlet-singlet excitation energies were calculated at the same level of theory, and the spectra were reproduced as the superposition of Gaussian functions with heights proportional to calculated intensities and a variance of 11 nm.
Cell culture
H9c2 rat cardiomyoblast cells were maintained in high-glucose (4500 mg/L) DMEM medium (Sigma-Aldrich, USA) containing 10% fetal bovine serum (FBS; In Vitro Technologies, USA) and 2 mM L-glutamine (Sigma-Aldrich, USA) at 37 ºC and 5% CO 2 . The H9c2 cells were cultured in 75 mm 2 flasks. Cells that had been passaged for no more than 18 times, were used for experiments.
For ICP-MS, H9c2 cells were seeded at 2. 
ICP-MS
The H9c2 cells were incubated with the iridium complexes at 20 µM (prepared in DMEM full culture media with 0.2% DMSO) for 30 minutes at 37 ºC and 5% CO 2 . The cells were washed three times with phosphate buffered saline (PBS), and then detached with TripLE Express reagent (Gibco, USA) for 2 minutes. The cells were then washed from T25 flasks with 3 mL of DMEM full culture medium, and pelleted by centrifugation at 400 rpm for 10 minutes. The medium was removed and the cells were resuspended in 2 mL of PBS for cells counts. The remaining cells were centrifuged at 1000 rpm for 10 minutes, the medium was then removed leaving behind the stained cell pellets, which were desiccated for 3.5 h at 95 °C. The pellets were reconstituted in 36% HCl (400 µL) and left at 95 °C until dry in order to digest organic material. The dry samples were then reconstituted in 2% HCl (2.5 mL) and sonicated for 10 minutes before filtering (pore diameter of 0.2 µm). The total iridium determination was performed with an Agilent 8900x triple quad ICP-MS (Agilent Technologies, USA), using He gas (4 mL/min).
Cell staining
H9c2 cells were incubated with the iridium complexes at 20 µM in DMEM full culture medium with 0.2% DMSO for 30 minutes at either 37 ºC or 4 ºC. The cells were washed twice with PBS, before imaging in DMEM. For co-staining experiments, the cells were then incubated with ER-Tracker ™ Red, MitoTracker ® Red CMXRos, or BODIPY ® 500/510 C 1 ,C 12 (Life Technologies Australia Pty Ltd, Australia), following manufacturer's instructions.
Confocal micoscopy
Single photon live cell imaging was performed using a Nikon A1+ confocal microscope (Nikon, Japan) with a OKOLab Microscope Incubator (Okolab USA Inc., USA). The iridium complexes were excited at 403 nm and the emission was collected in the 525-644 nm region; ER-Tracker and
MitoTracker were excited at 561 nm and the emission was collected in the region 570-620 nm.
BODIPY 500/510 was excited at 488 nm and the emission was collected in the region 500-550 nm.
Image analysis including, co-localisation and emission intensity was measured using NIS elements V4.50 software (Nikon, Japan). The final preparation of the images was conducted with Adobe
Photoshop CC (Adobe Systems Inc., USA). Two-photon microscopy imaging was performed using a Zeiss LSM710 META NLO inverted microscope supplemented with a two-photon Mai-Tai®, tunable Ti:Sapphire femtosecond pulse laser (710-920 nm, Spectra-Physics). The emission from the iridium complexes was detected using the following settings: two-photon excitation wavelength at 830 nm, beam splitter MBS 690+, emission interval 520-650 nm. The images were acquired using a Plan-APOCHROMAT 63X/ NA1.4 oil immersion objective. The final preparation of the images was conducted with Adobe Photoshop CC (Adobe Systems Inc., USA).
MTS cell viability assay
The cellular NADPH-dependent redox activity was measured using CellTiter 96 ® AQueous Non-Radioactive Cell Proliferation Assay (MTS), according to the manufacturer's instruction (Promega, USA). The H9c2 cells were stained with the iridium complexes at either 20 µM or 40 µM in DMEM full cell culture medium with 0.2% DMSO, and held at 37 °C and 5% CO 2 for 4 or 24
hours. As a control, H9c2 cells were incubated for the same length of time in DMEM with 0.2%
DMSO. Following addition of MTS, the cells incubation for a further 2 hours at 37 ºC and 5% which is supported by the Australian Government.
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